766 DEVELOPMENT OF A HYPERGLYCOSYLATEDIFN ALFAC0N1 (CIFN): TOWARDS BIMONTHLY OR MONTHLY DOSING FOR ANTIVIRAL THERAPIES IN DISEASES SUCH AS CHRONIC HEPATITIS C
2011
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI